Alector (ALEC) Cash from Financing Activities (2018 - 2026)
Alector (ALEC) posted quarterly Cash from Financing Activities of $25000.0 for Q1 2026, down 99.54% quarter-over-quarter from $5.4 million in Q4 2025.
Alector (ALEC) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Cash from Financing Activities for 9 consecutive years, with $25000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $25000.0; the TTM figure through Mar 2026 stood at $20.2 million (up 94.02% YoY), while the FY2025 annual figure was $20.2 million, down 75.21% from the prior year.
- Cash from Financing Activities retreated to $25000.0 in Q1 2026 per ALEC's latest filing, from $5.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $71.1 million in Q1 2024 and bottomed at $25000.0 in Q1 2026.
- Historically, Cash from Financing Activities has averaged $7.8 million across 5 years, with a median of $893500.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 96.7% — and 2024, when it surged 6490.18%.
- Alector's Cash from Financing Activities stood at $636000.0 in 2022, then slipped by 7.23% to $590000.0 in 2023, then soared by 1558.98% to $9.8 million in 2024, then slumped by 44.91% to $5.4 million in 2025, then slumped by 99.54% to $25000.0 in 2026.
- Business Quant data shows ALEC's Cash from Financing Activities at $25000.0 in Q1 2026, $5.4 million in Q4 2025, and $14.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.42 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -6.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -207,909.22 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -273.15 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.24 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 27.18 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50,000.00 |
| Jun 30, 2026 | 50,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 5.39 Mn |
| Dec 31, 2025 | 5.39 Mn |
| Sep 30, 2025 | 14.70 Mn |
| Sep 30, 2025 | 14.70 Mn |
| Jun 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Dec 31, 2024 | 9.79 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Jun 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 71.11 Mn |
| Mar 31, 2024 | 71.11 Mn |
| Dec 31, 2023 | 590,000.00 |
| Dec 31, 2023 | 590,000.00 |
| Jun 30, 2023 | 881,000.00 |
| Jun 30, 2023 | 881,000.00 |